Prior receipt of palivizumab prophylaxis among patients admitted to the Pediatric Intensive Care Unit with Respiratory Syncytial Virus: A retrospective cohort study
— · The Internet Journal of Pediatrics and Neonatology · 2008
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
The Internet Journal of Pediatrics and Neonatology · OpenAlex · article · 2008
Abstract
Objectives: To determine whether children in a pediatric intensive care unit (PICU) with respiratory syncytial virus (RSV) infection had been given palivizumab in the primary care setting when indicated and compare outcomes among those who had or had not. Results: 118 patients (32%) met criteria for palivizumab. 71% of those were documented to have received it. Age, birthweight, gestational age, and rate of chronic lung disease did not differ between children who did or did not receive palivizumab. All who did not receive palivizumab had public insurance.
Length of stay was longer for those who received palivizumab vs. not (p=0.047), and more patients who received it required mechanical ventilation (p=0.009). Conclusions: A minority of PICU patients with RSV had missed palivizumab prophylaxis. Those who received palivizumab had worse outcomes, but in a retrospective study, this is most likely due to a selection bias rather than because they had received palivizumab.
Open the resolved locator · 10.5580/593
Metadata licence: OpenAlex metadata (CC0)